RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jodie Fleming to Gene Expression Regulation, Neoplastic

This is a "connection" page, showing publications Jodie Fleming has written about Gene Expression Regulation, Neoplastic.
  1. Fleming JM, Ginsburg E, Oliver SD, Goldsmith P, Vonderhaar BK. Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer. BMC Cancer. 2012 Jun 22; 12:266.
    View in: PubMed
    Score: 0.250
  2. Fagan-Solis KD, Reaves DK, Rangel MC, Popoff MR, Stiles BG, Fleming JM. Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer. Mol Cancer. 2014 Jul 02; 13:163.
    View in: PubMed
    Score: 0.072
  3. Waly AA, Harper L, Fleming JM, Costantini LM. CRY?B2 alters cell adhesion to promote invasion in a triple-negative breast cancer cell line. BMC Res Notes. 2025 Jan 21; 18(1):26.
    View in: PubMed
    Score: 0.037
  4. D'Arcy M, Fleming J, Robinson WR, Kirk EL, Perou CM, Troester MA. Race-associated biological differences among Luminal A breast tumors. Breast Cancer Res Treat. 2015 Jul; 152(2):437-48.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support